Developer docs
API playgroundTry for free, no card

Search company profiles

NuvoAir

Full company profile

uuid0000p7o

Namestring
NuvoAir
Legal namestring
NuvoAir US Inc.
Websiteurl
nuvoair.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

NuvoAir (operating commercially as NuvoAir Medical) is a Boston-based, venture-backed digital health company that delivers virtual-first specialty care for patients with chronic cardiopulmonary conditions including COPD, asthma, heart failure, hypertension, and sleep disorders. The company's care model combines FDA-cleared at-home monitoring hardware with mobile applications, a provider dashboard, and multidisciplinary clinical teams to provide continuous remote care aimed at predicting exacerbations and reducing hospitalizations. Founded in 2015 with a European research and development base in Stockholm, Sweden, NuvoAir now operates clinics in Prescott and Tucson, Arizona alongside virtual care services covered by more than 100 health plans including Anthem, Centene, Humana, Cigna, UnitedHealthcare, Medicare, and Medicaid.

The core technology stack centers on the Air Next Spirometer — a Bluetooth-connected, FDA 510(k)-cleared and CE-certified Class IIa medical device validated against ATS/ISO standard curves — paired with the NuvoAir Home mobile application (iOS/Android, supporting English, French, German, Italian, Spanish, Swedish, and Dutch), the Air MD professional spirometry app, and the NuvoAir Cough companion app. The platform integrates with Apple HealthKit, Hailie® asthma sensors, and the proprietary NuvoAir Aos inhaler add-on sensor. The provider-facing dashboard unifies outreach, diagnostics, and analytics. Sub-brands include Incredible Heart (cardiology-focused care including weight management and immigration medical examination services) and NuvoAir Cough. Disclosed clinical outcomes include a 31% reduction in all-cause hospitalizations, 52% decrease in total hospital days, 77% drop in all-cause readmissions, and 27% reduction in total medical spend among COPD patients in a published research preprint.

NuvoAir operates a hybrid revenue model spanning (1) subscription-based virtual care services reimbursed by health plans, (2) hardware sales of the Air Next spirometer and consumable disposable turbines, (3) decentralized clinical trial services for pharmaceutical companies and CROs, and (4) clinic-based fee-for-service revenue. Go-to-market combines enterprise field sales targeting health plans, ACOs, and risk-bearing entities (e.g., Privia Medical Group Georgia with 515,000 patient reach and Cary Medical Management for rural North Carolina), partnerships with health systems taking over specialty clinics (Dignity Health Yavapai Regional Medical Group), direct-to-consumer mobile app distribution via the iOS App Store and Google Play, and company-operated physical clinics. The company has raised approximately $28 million across disclosed funding rounds since 2017, including a $12 million Series A led by AlbionVC with Novartis participation in 2021 and a subsequent approximately $10.7 million round in January 2022.

Short descriptiontext

NuvoAir Medical is a Boston-based virtual-first specialty care platform delivering AI-driven cardiopulmonary care for patients with chronic heart and lung conditions. It combines FDA-cleared at-home monitoring devices, mobile apps, and multidisciplinary clinical teams to reduce hospitalizations, and is covered by 100+ health plans.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual care platform, remote patient monitoring, cardiopulmonary care services, chronic disease management, decentralized clinical trials
Industry2 codes
1Primary Care & General Medicine Virtual Care
CodeHLALAAAAPrimaryYes
2Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
CodeHLALACAEPrimaryNo
NAICS code1 code
  • Services for the Elderly and Persons with Disabilities62412
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Home Health Care Services8082
Product category
Virtual Specialty Care Platform
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Virtual Care Services
TypeSubscription Recurring
Description

Subscription-based care services covered by health plans including Medicare, Medicaid, and commercial insurers. The company provides ongoing virtual care management for patients with chronic cardiopulmonary conditions with continuous monitoring and support.

nuvoair.com
2Medical Device Sales
TypeHardware Sales
Description

Sale of Air Next spirometer devices and consumables (disposable turbines) to patients and healthcare providers for at-home lung function monitoring.

nuvoair.com
3Clinical Trial Services
TypeProfessional Services
Description

Clinical trial services and decentralized clinical trial support for pharmaceutical companies and CROs. NuvoAir provides remote patient monitoring, diagnostics, and data collection for respiratory and cardiopulmonary clinical research.

nuvoair.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Insurance-covered care services
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Services covered by 100+ health plans including major insurers such as Anthem, Centene, Humana, Cigna, and UnitedHealthcare. Patient responsibility determined by insurance coverage.

nuvoair.com
2Immigration Exam - $439
ModelOne time/ perpetual licenseBilling cadenceOne time
Notes

$439 fee includes two office visits for immigration medical examination (Form I-693). Payment due at first visit.

info.nuvoair.com
3Incredible Heart Cardiac Care - Insurance-based
ModelOtherBilling cadenceMulti-year contract
Notes

Incredible Heart cardiac membership services offered at no extra cost beyond insurance copay.

info.nuvoair.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1Air Next Spirometer
Description

Award-winning professional spirometer designed for home use, CE certified Class IIa Medical Device with FDA 510k clearance. Used with NuvoAir Home app for respiratory monitoring.

play.google.com
+2 more records
Core offering1 text field

NuvoAir delivers virtual-first specialty care for chronic heart and lung conditions, combining FDA-cleared at-home monitoring devices (Air Next Spirometer) with AI-driven software, multidisciplinary care teams, and connected mobile apps for continuous remote patient management. Its services are billed to over 100 health plans (including Medicare, Medicaid, and major commercial insurers), with additional revenue from medical device sales and decentralized clinical trial services for pharmaceutical clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 31% reduction in all-cause hospitalizations
+4 more records
Product overview1 text field

NuvoAir Medical is a digital health company offering a virtual-first cardiopulmonary care platform that combines FDA-cleared at-home monitoring devices with AI-driven technology and multidisciplinary clinical care teams. The core product ecosystem includes the NuvoAir Home App (patient-facing respiratory monitoring), Air Next Spirometer (FDA 510(k) cleared Bluetooth-connected device), and Air MD (professional spirometry version). The platform delivers services for COPD, asthma, heart failure, hypertension, sleep disorders, and weight management. Supporting offerings include NuvoAir Cough for respiratory monitoring and Incredible Heart for specialized cardiac care. The company operates pulmonary clinics in Tucson and Prescott, Arizona, and partners with health plans (100+ including major insurers), healthcare providers, and pharmaceutical companies across the U.S. and Europe.

Product and service10 records
1NuvoAir Home App
CategoryMobile Health Software
Description

Patient-facing mobile application that connects via Bluetooth to the Air Next spirometer to enable at-home respiratory monitoring, lung function insights, medication and symptom tracking, and automatic data sharing with healthcare providers.

2Air Next Spirometer
CategoryMedical Device
Description

FDA 510(k) cleared and CE certified Class IIa Bluetooth spirometer measuring FEV1, FVC, and PEF with clinical-grade accuracy, featuring maintenance-free disposable turbines and a 10-year expected lifespan.

3Air MD
CategoryClinical Software
Description

Professional spirometry app for healthcare providers, supporting up to 8 tests per session with spirometry session grading based on ATS/ERS standards.

4NuvoAir Cough
CategoryMobile Health Software
Description

Companion mobile app for cough tracking and respiratory monitoring within NuvoAir's respiratory care ecosystem.

5NuvoAir Home Care Service
CategoryVirtual Care Service
Description

Virtual-first specialty care service for cardiopulmonary conditions including COPD, asthma, heart failure, and sleep disorders, combining remote monitoring with multidisciplinary care teams for proactive, continuous care.

6Remote Patient Monitoring Service
CategoryRemote Patient Monitoring
Description

Continuous at-home monitoring service using FDA-cleared devices to track respiratory metrics, enabling early detection of health changes and proactive intervention before exacerbations require hospitalization.

7Incredible Heart
CategoryCardiac Care Service
Description

Cardiac care service offering virtual and in-person consultations, at-home monitoring devices, and cardiologist services covering heart failure, hypertension, atrial fibrillation, and arrhythmia.

8Incredible Heart Weight Management Program
CategoryWeight Management Service
Description

Insurance-approved weight management program supervised by board-certified cardiologists, providing diet and lifestyle guidance, weight loss medications, and smart weight scales delivered to patients' homes.

9Immigration Medical Examination
CategoryClinical Examination Service
Description

USCIS-designated civil surgeon service providing Form I-693 Immigration Medical Examinations, including two office visits and guidance through the immigration exam process for a flat fee of $439.

10Decentralized Clinical Trial Services
CategoryClinical Research Services
Description

Clinical trial services for pharmaceutical companies and CROs providing remote patient monitoring, diagnostics, and data collection for respiratory and cardiopulmonary clinical research.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-15
Description

NuvoAir Medical opened outpatient pulmonary clinic in Prescott, AZ to continue care established by Dignity Health Yavapai Regional Medical Group. Ensures continued access to high-quality outpatient pulmonary care for Prescott-area residents transitioning from YRMG.

2Dresden Pulmonology
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-07-29
Description

Partnership to elevate respiratory care in rural Tennessee. NuvoAir's virtual-first care model combined with Dresden Pulmonology's local expertise to improve access to specialty cardiopulmonary care.

nuvoair.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-30
Description

Collaboration to enhance access to high-quality cardiopulmonary care for patients throughout Georgia. NuvoAir's multidisciplinary team extends specialty care for COPD, CHF, and Asthma patients, integrating with PMG's network of 380+ providers caring for over 515,000 patients. Represents significant expansion through state's highest performing ACO.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-08
Description

Partnership to bring high-quality specialty cardiopulmonary care to patients in rural North Carolina. NuvoAir enables primary care clinics under CMM's management to provide in-home and virtual care for patients with complex heart and lung issues including Asthma, COPD, and CHF. This addresses the shortage of respiratory and cardiac specialists in rural areas.

5Various Healthcare Providers
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnerships with various healthcare providers and pharmaceutical companies across U.S., U.K., and Europe for respiratory disease management and clinical trial services.

prnewswire.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Propeller Health is a digital respiratory health company focused on asthma and COPD management via inhaler sensors and a mobile app, now owned by ResMed. Directly comparable to NuvoAir on target conditions (COPD, asthma), at-home monitoring, and payer-aligned chronic care delivery.

TypeDirect peer
Description

Wellinks offers virtual-first cardiopulmonary care combining remote monitoring, coaching, and clinical care for COPD and other chronic conditions. Closely comparable business model to NuvoAir with overlapping payer, provider, and chronic-condition VBC strategies.

TypeBroad incumbent
Description

Omada Health is an established virtual chronic disease management platform covering diabetes, hypertension, and behavioral health, serving payers, employers, and health systems. Comparable to NuvoAir in chronic-condition VBC orientation and payer contracting motion, though broader in therapeutic scope.

TypeBroad incumbent
Description

Vivify Health provides a remote patient monitoring platform used by health systems and payers to manage chronic and post-acute patients at home. Comparable to NuvoAir on the RPM infrastructure layer and enterprise health-plan/channel distribution.

TypeEmerging player
Description

Biofourmis combines wearable-based RPM with AI predictive analytics for chronic and post-acute care, including cardiology. Overlaps with NuvoAir on RPM + AI-enabled chronic disease management and health plan / pharma channels.

TypeDirect peer
Description

Hinge Health is a virtual specialty care platform delivering condition-specific digital care programs (musculoskeletal) to payers and employers. Comparable to NuvoAir on virtual specialty model, employer/payer GTM, and outcome-anchored value proposition.

TypeDirect peer
Description

Eko Health builds AI-enabled cardiopulmonary diagnostic tools, including connected stethoscopes and digital auscultation, used in clinical and remote settings. Directly comparable to NuvoAir on connected cardiopulmonary hardware, AI analytics, and clinical integration.

TypeBroad incumbent
Description

ResMed is a global leader in sleep and respiratory care devices and the parent of Propeller Health, with deep payer and provider distribution. Comparable to NuvoAir on respiratory/sleep therapy DME, connected device strategy, and chronic cardiopulmonary patient base.

TypeEmerging player
Description

Lark Health delivers AI-driven chronic condition coaching and remote monitoring for cardiovascular and metabolic conditions via a mobile platform. Comparable to NuvoAir on AI-enabled virtual chronic disease management and payer-aligned GTM.

TypeBroad incumbent
Description

Teladoc Health operates one of the largest virtual care platforms, including the legacy Livongo chronic condition management business. Overlaps with NuvoAir on virtual specialty care, RPM, and chronic condition management delivered to payers and health systems.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NuvoAir

Virtual Specialty Care Platformnuvoair.com

NuvoAir Medical is a Boston-based virtual-first specialty care platform delivering AI-driven cardiopulmonary care for patients with chronic heart and lung conditions. It combines FDA-cleared at-home monitoring devices, mobile apps, and multidisciplinary clinical teams to reduce hospitalizations, and is covered by 100+ health plans.

What NuvoAir does

NuvoAir (operating commercially as NuvoAir Medical) is a Boston-based, venture-backed digital health company that delivers virtual-first specialty care for patients with chronic cardiopulmonary conditions including COPD, asthma, heart failure, hypertension, and sleep disorders. The company's care model combines FDA-cleared at-home monitoring hardware with mobile applications, a provider dashboard, and multidisciplinary clinical teams to provide continuous remote care aimed at predicting exacerbations and reducing hospitalizations. Founded in 2015 with a European research and development base in Stockholm, Sweden, NuvoAir now operates clinics in Prescott and Tucson, Arizona alongside virtual care services covered by more than 100 health plans including Anthem, Centene, Humana, Cigna, UnitedHealthcare, Medicare, and Medicaid.

The core technology stack centers on the Air Next Spirometer — a Bluetooth-connected, FDA 510(k)-cleared and CE-certified Class IIa medical device validated against ATS/ISO standard curves — paired with the NuvoAir Home mobile application (iOS/Android, supporting English, French, German, Italian, Spanish, Swedish, and Dutch), the Air MD professional spirometry app, and the NuvoAir Cough companion app. The platform integrates with Apple HealthKit, Hailie® asthma sensors, and the proprietary NuvoAir Aos inhaler add-on sensor. The provider-facing dashboard unifies outreach, diagnostics, and analytics. Sub-brands include Incredible Heart (cardiology-focused care including weight management and immigration medical examination services) and NuvoAir Cough. Disclosed clinical outcomes include a 31% reduction in all-cause hospitalizations, 52% decrease in total hospital days, 77% drop in all-cause readmissions, and 27% reduction in total medical spend among COPD patients in a published research preprint.

NuvoAir operates a hybrid revenue model spanning (1) subscription-based virtual care services reimbursed by health plans, (2) hardware sales of the Air Next spirometer and consumable disposable turbines, (3) decentralized clinical trial services for pharmaceutical companies and CROs, and (4) clinic-based fee-for-service revenue. Go-to-market combines enterprise field sales targeting health plans, ACOs, and risk-bearing entities (e.g., Privia Medical Group Georgia with 515,000 patient reach and Cary Medical Management for rural North Carolina), partnerships with health systems taking over specialty clinics (Dignity Health Yavapai Regional Medical Group), direct-to-consumer mobile app distribution via the iOS App Store and Google Play, and company-operated physical clinics. The company has raised approximately $28 million across disclosed funding rounds since 2017, including a $12 million Series A led by AlbionVC with Novartis participation in 2021 and a subsequent approximately $10.7 million round in January 2022.

NuvoAir firmographics

Firmographics
Name
NuvoAir
Legal name
NuvoAir US Inc.
Website
https://nuvoair.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
NuvoAir Medical is a Boston-based virtual-first specialty care platform delivering AI-driven cardiopulmonary care for patients with chronic heart and lung conditions. It combines FDA-cleared at-home monitoring devices, mobile apps, and multidisciplinary clinical teams to reduce hospitalizations, and is covered by 100+ health plans.
Ownership category
akta.pro rank

NuvoAir industry classification

Industry
Product category
Virtual Specialty Care Platform
NAICS
Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
akta.pro primary industry
Primary Care & General Medicine Virtual Care (HLALAAAA)
akta.pro secondary industry
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)

Keywords

  • Virtual care platform
  • Remote patient monitoring
  • Cardiopulmonary care services
  • Chronic disease management
  • Decentralized clinical trials

Where NuvoAir is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices6 records

Markets served

NuvoAir business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Virtual Care Services: Subscription-based care services covered by health plans including Medicare, Medicaid, and commercial insurers. The company provides ongoing virtual care management for patients with chronic cardiopulmonary conditions with continuous monitoring and support.
  2. Medical Device Sales: Sale of Air Next spirometer devices and consumables (disposable turbines) to patients and healthcare providers for at-home lung function monitoring.
  3. Clinical Trial Services: Clinical trial services and decentralized clinical trial support for pharmaceutical companies and CROs. NuvoAir provides remote patient monitoring, diagnostics, and data collection for respiratory and cardiopulmonary clinical research.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractInsurance-covered care services
One time/ perpetual licenseOne timeImmigration Exam - $439
OtherMulti-year contractIncredible Heart Cardiac Care - Insurance-based

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

NuvoAir product offering

Product offering

Core offering

NuvoAir delivers virtual-first specialty care for chronic heart and lung conditions, combining FDA-cleared at-home monitoring devices (Air Next Spirometer) with AI-driven software, multidisciplinary care teams, and connected mobile apps for continuous remote patient management. Its services are billed to over 100 health plans (including Medicare, Medicaid, and major commercial insurers), with additional revenue from medical device sales and decentralized clinical trial services for pharmaceutical clients.

Product overview

NuvoAir Medical is a digital health company offering a virtual-first cardiopulmonary care platform that combines FDA-cleared at-home monitoring devices with AI-driven technology and multidisciplinary clinical care teams. The core product ecosystem includes the NuvoAir Home App (patient-facing respiratory monitoring), Air Next Spirometer (FDA 510(k) cleared Bluetooth-connected device), and Air MD (professional spirometry version). The platform delivers services for COPD, asthma, heart failure, hypertension, sleep disorders, and weight management. Supporting offerings include NuvoAir Cough for respiratory monitoring and Incredible Heart for specialized cardiac care. The company operates pulmonary clinics in Tucson and Prescott, Arizona, and partners with health plans (100+ including major insurers), healthcare providers, and pharmaceutical companies across the U.S. and Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • Air Next Spirometer: Award-winning professional spirometer designed for home use, CE certified Class IIa Medical Device with FDA 510k clearance. Used with NuvoAir Home app for respiratory monitoring.
  • NuvoAir Home
  • Air MD

Products and services

  • NuvoAir Home App Patient-facing mobile application that connects via Bluetooth to the Air Next spirometer to enable at-home respiratory monitoring, lung function insights, medication and symptom tracking, and automatic data sharing with healthcare providers.
  • Air Next Spirometer FDA 510(k) cleared and CE certified Class IIa Bluetooth spirometer measuring FEV1, FVC, and PEF with clinical-grade accuracy, featuring maintenance-free disposable turbines and a 10-year expected lifespan.
  • Air MD Professional spirometry app for healthcare providers, supporting up to 8 tests per session with spirometry session grading based on ATS/ERS standards.
  • NuvoAir Cough Companion mobile app for cough tracking and respiratory monitoring within NuvoAir's respiratory care ecosystem.
  • NuvoAir Home Care Service Virtual-first specialty care service for cardiopulmonary conditions including COPD, asthma, heart failure, and sleep disorders, combining remote monitoring with multidisciplinary care teams for proactive, continuous care.
  • Remote Patient Monitoring Service Continuous at-home monitoring service using FDA-cleared devices to track respiratory metrics, enabling early detection of health changes and proactive intervention before exacerbations require hospitalization.
  • Incredible Heart Cardiac care service offering virtual and in-person consultations, at-home monitoring devices, and cardiologist services covering heart failure, hypertension, atrial fibrillation, and arrhythmia.
  • Incredible Heart Weight Management Program Insurance-approved weight management program supervised by board-certified cardiologists, providing diet and lifestyle guidance, weight loss medications, and smart weight scales delivered to patients' homes.
  • Immigration Medical Examination USCIS-designated civil surgeon service providing Form I-693 Immigration Medical Examinations, including two office visits and guidance through the immigration exam process for a flat fee of $439.
  • Decentralized Clinical Trial Services Clinical trial services for pharmaceutical companies and CROs providing remote patient monitoring, diagnostics, and data collection for respiratory and cardiopulmonary clinical research.

Quantifiable outcome

  • 31% reduction in all-cause hospitalizations
  • +4 more outcomes

Companies that use NuvoAir

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

NuvoAir technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature4 records

NuvoAir partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Dignity Health Yavapai Regional Medical GroupcoreStrategic or Co-development Partner · 15 October 2024NuvoAir Medical opened outpatient pulmonary clinic in Prescott, AZ to continue care established by Dignity Health Yavapai Regional Medical Group. Ensures continued access to high-quality outpatient pulmonary care for Prescott-area residents transitioning from YRMG.
  • Dresden PulmonologyminorStrategic or Co-development Partner · 29 July 2024Partnership to elevate respiratory care in rural Tennessee. NuvoAir's virtual-first care model combined with Dresden Pulmonology's local expertise to improve access to specialty cardiopulmonary care.
  • Privia Medical Group - GeorgiacoreStrategic or Co-development Partner · 30 April 2024Collaboration to enhance access to high-quality cardiopulmonary care for patients throughout Georgia. NuvoAir's multidisciplinary team extends specialty care for COPD, CHF, and Asthma patients, integrating with PMG's network of 380+ providers caring for over 515,000 patients. Represents significant expansion through state's highest performing ACO.
  • Cary Medical ManagementcoreStrategic or Co-development Partner · 8 January 2024Partnership to bring high-quality specialty cardiopulmonary care to patients in rural North Carolina. NuvoAir enables primary care clinics under CMM's management to provide in-home and virtual care for patients with complex heart and lung issues including Asthma, COPD, and CHF. This addresses the shortage of respiratory and cardiac specialists in rural areas.
  • Various Healthcare ProvidersminorStrategic or Co-development PartnerPartnerships with various healthcare providers and pharmaceutical companies across U.S., U.K., and Europe for respiratory disease management and clinical trial services.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

NuvoAir competitors and assessment

Company assessment

Direct peers

  • Propeller Health: Propeller Health is a digital respiratory health company focused on asthma and COPD management via inhaler sensors and a mobile app, now owned by ResMed. Directly comparable to NuvoAir on target conditions (COPD, asthma), at-home monitoring, and payer-aligned chronic care delivery.
  • Wellinks: Wellinks offers virtual-first cardiopulmonary care combining remote monitoring, coaching, and clinical care for COPD and other chronic conditions. Closely comparable business model to NuvoAir with overlapping payer, provider, and chronic-condition VBC strategies.
  • Hinge Health: Hinge Health is a virtual specialty care platform delivering condition-specific digital care programs (musculoskeletal) to payers and employers. Comparable to NuvoAir on virtual specialty model, employer/payer GTM, and outcome-anchored value proposition.
  • Eko Health: Eko Health builds AI-enabled cardiopulmonary diagnostic tools, including connected stethoscopes and digital auscultation, used in clinical and remote settings. Directly comparable to NuvoAir on connected cardiopulmonary hardware, AI analytics, and clinical integration.

Broad incumbents

  • Omada Health: Omada Health is an established virtual chronic disease management platform covering diabetes, hypertension, and behavioral health, serving payers, employers, and health systems. Comparable to NuvoAir in chronic-condition VBC orientation and payer contracting motion, though broader in therapeutic scope.
  • Vivify Health: Vivify Health provides a remote patient monitoring platform used by health systems and payers to manage chronic and post-acute patients at home. Comparable to NuvoAir on the RPM infrastructure layer and enterprise health-plan/channel distribution.
  • ResMed: ResMed is a global leader in sleep and respiratory care devices and the parent of Propeller Health, with deep payer and provider distribution. Comparable to NuvoAir on respiratory/sleep therapy DME, connected device strategy, and chronic cardiopulmonary patient base.
  • Teladoc Health: Teladoc Health operates one of the largest virtual care platforms, including the legacy Livongo chronic condition management business. Overlaps with NuvoAir on virtual specialty care, RPM, and chronic condition management delivered to payers and health systems.

Emerging players

  • Biofourmis: Biofourmis combines wearable-based RPM with AI predictive analytics for chronic and post-acute care, including cardiology. Overlaps with NuvoAir on RPM + AI-enabled chronic disease management and health plan / pharma channels.
  • Lark Health: Lark Health delivers AI-driven chronic condition coaching and remote monitoring for cardiovascular and metabolic conditions via a mobile platform. Comparable to NuvoAir on AI-enabled virtual chronic disease management and payer-aligned GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

NuvoAir social profiles

Digital presence

NuvoAir compliance and trust

Trust signal

Compliance6 records

NuvoAir financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NuvoAir leadership team

Management profile

Number of profiles

Profiles6 records

NuvoAir funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NuvoAir M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NuvoAir

What does NuvoAir do?

NuvoAir delivers virtual-first specialty care for chronic heart and lung conditions, combining FDA-cleared at-home monitoring devices (Air Next Spirometer) with AI-driven software, multidisciplinary care teams, and connected mobile apps for continuous remote patient management. Its services are billed to over 100 health plans (including Medicare, Medicaid, and major commercial insurers), with additional revenue from medical device sales and decentralized clinical trial services for pharmaceutical clients.

Is NuvoAir a public or private company?

NuvoAir is a private company. It is classified as venture growth investor backed and is currently operating.

When was NuvoAir founded?

NuvoAir was founded in 2015. It employs 51 to 100 people.

Where is NuvoAir based?

NuvoAir is headquartered in Boston, United States, in the North America region.

How does NuvoAir make money?

Three revenue lines are on record. Virtual Care Services are the primary driver. The others are medical Device Sales and clinical Trial Services.

Who are NuvoAir's main competitors?

Direct peers on record are Propeller Health, Wellinks, Hinge Health and Eko Health. Broad incumbents are Omada Health, Vivify Health, ResMed and Teladoc Health. Emerging players are Biofourmis and Lark Health.

Does NuvoAir have an API?

Yes. NuvoAir offers an API exchange system for data exchange with partners. The privacy policy states: "The data exchange might be done via our API exchange system, or via Apple HealthKit's API." Data types exchanged include health data such as spirometry results, medications, and questionnaire responses. Data sharing with partners requires prior explicit consent from users.

What industry is NuvoAir in?

NuvoAir's product category is Virtual Specialty Care Platform. Its primary akta.pro industry code is HLALAAAA, Primary Care & General Medicine Virtual Care, with a secondary code of HLALACAE, Chronic Condition Virtual Care & Disease Management (Payer-Sponsored). Its NAICS code is 62412 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizStrados Labs Acquires NuvoAir Clinical Trials Business to Expand Respiratory Research PlatformStrados Labs acquired NuvoAir's clinical trials business, closing in March 2026, adding spirometry, airway inflammation testing, and patient outcome tools to its respiratory research platform. Financial terms were not disclosed. The combined platform, to be marketed as the Strados Endpoint Suite, has been used in over 55 clinical trials globally.BioSpaceStrados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life SciencesStrados Labs acquired NuvoAir Clinical Trials, closing in March 2026, to add remote and in-clinic spirometry, FeNO measurement, and eCOA to its respiratory endpoint suite. The combined suite covers Phase I through Phase IV trials for COPD, asthma, and chronic cough, with over 55 clinical trials deployed.Respiratory TherapyFDA Clears Air Next Spirometer for Home UseNuvoAir Medical received 510(k) clearance from the US Food and Drug Administration for its Air Next spirometer, allowing it to be used for in-home monitoring of lung conditions. This approval enables the device to conduct full spirometry compliant with American Thoracic Society standards for clinical trials across the US and Europe. The move aims to provide continuous patient data to clinical teams, facilitating early intervention for conditions like COPD and asthma.Business Wire BlogNuvoAir’s Air Next Spirometer Is FDA-Approved for In-Home UseNuvoAir Medical announced that its Air Next Spirometer has received FDA 510(k) clearance for in-home use as a full spirometer. This regulatory approval allows the company to conduct ATS 2019-compliant spirometry for clinical trials and patient monitoring in the US and Europe. The device enables continuous lung function data collection at home, aiming to improve care for patients with heart and lung conditions.Business Wire BlogNuvoAir and Cary Medical Management announce partnership to bring high-quality cardiopulmonary care to rural North CarolinaNuvoAir Medical and Cary Medical Management announced a partnership to bring virtual cardiopulmonary care to North Carolina clinics. The collaboration will enable in-home and virtual care for patients with asthma, COPD, and CHF, aiming to lower costs and improve outcomes amid a specialist shortage.PR NewswireMARPAI COLLABORATES WITH NUVOAIR TO OFFER VALUE-BASED CARDIOPULMONARY CARE TO SELF-FUNDED EMPLOYER HEALTH PLANSMarpai, Inc. announced a collaboration with NuvoAir U.S., Inc. to add virtual cardiopulmonary care services for conditions including asthma, COPD, and chronic heart failure to its value-based care network for self-funded employer health plans. The partnership aims to serve Marpai's members with these conditions, which currently cost plans over $12 million per year, by leveraging NuvoAir's virtual-first care model that has demonstrated a reported 80% decrease in hospitalizations and 87% improvement in quality of life. NuvoAir is currently available across 15 U.S. states and operates under a value-based payment structure where employers only pay for actual member participation.citybizKaren Piacentini and Alexander Packard Join NuvoAir’s Board of DirectorsNuvoAir appointed Karen Piacentini and Alexander Packard to its Board of Directors to support its expansion in virtual-first care for cardio-pulmonary conditions. The new board members bring extensive experience from healthcare organizations such as Optum, UnitedHealthcare, and Iora Health to help align payor needs with NuvoAir's value-based care solutions.GlobeNewswireScience 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical TrialsScience 37 and NuvoAir announced a partnership to incorporate remote respiratory endpoint data collection into clinical trials, enabling home-based lung function testing. The collaboration aims to reduce patient burden and expand trial participation, with NuvoAir's solution supporting decentralized trial designs.PR NewswireNuvoAir US COPD Pilot Demonstrates Strong Patient Engagement, a Reduction in Hospitalizations, and Improved Quality of LifeNuvoAir, a digital health company, released results from its U.S. COPD pilot conducted from 2021-2022 with rural populations in Indiana and Kentucky, showing that 80% of surveyed patients reported fewer hospitalizations, 60% fewer exacerbations, and 87% improved quality of life. The virtual-first solution uses the company's proprietary Air Next spirometer and Aos inhaler sensor paired with clinical teams to provide continuous, proactive care, following successful implementation with the NHS in the United Kingdom. The pilot enrolled 74% of its targeted population and addressed a significant healthcare challenge, as COPD is the third leading cause of disease-related death in the U.S. with projected annual costs approaching $50 billion.MobiHealthNewsRoundup: Women’s health startup raises $10M, NuvoAir launches remote asthma service, and more briefsWomen’s health startup Inne secured €9.3 million in funding led by DSM Venturing to expand its women's health platform in the U.S. and develop new features. Swedish startup NuvoAir partnered with 17 NHS trusts to launch a remote asthma management service, utilizing connected monitoring technology.